The method comes after the assessment. Nu‑V is one option, not the answer to every intimate concern.
Many women reach this page after searching for CO2 vaginal laser, laser vaginal rejuvenation or a non-surgical intimate treatment. Those searches often begin because something affecting comfort, tissue quality, support or confidence has changed.
At The Women’s Health Clinic, we do not assume that a named treatment is suitable simply because a particular symptom is present. We first consider the likely cause, whether medical review or another pathway should come first, and whether Nu‑V has a reasonable role at all.
The introductory call is a confidential first conversation. Clinical consultation and assessment are completed separately before treatment.
Questions this page is designed to answer
The purpose is to explain the method clearly before any decision is made.
“What does CO₂ intimate rejuvenation actually mean?”
“How is Nu‑V different from the wider vaginal rejuvenation pathway?”
“What needs to be assessed before CO₂ treatment is considered?”
“What do the evidence, risks, limitations and alternatives mean for informed choice?”
We separate the concern from the method
A symptom or personal concern does not automatically identify the correct treatment. The underlying context must be understood first.
We assess suitability before treatment
Medical history, symptoms, likely causes, red flags, anatomy and alternative pathways are considered before Nu‑V is discussed as an option.
We place the evidence in context
We explain what is known, where uncertainty remains, what treatment cannot achieve and when another approach may be more appropriate.
Non-surgical CO₂ laser vaginal rejuvenation explained
Nu‑V CO₂ Intimate Rejuvenation
Nu‑V is the name used at The Women’s Health Clinic for our clinic-based CO₂ laser pathway involving selected vaginal and vulval treatment areas.
The terms “CO2 vaginal laser”, “laser vaginal rejuvenation” and “non-surgical laser vaginal rejuvenation” are commonly used online. On this page, they refer specifically to the Nu‑V method — not to vaginal rejuvenation as a whole and not to a treatment suitable for every intimate health concern.
Similar symptoms can have different causes. Before Nu‑V is recommended, we consider your medical history, what has changed, possible underlying factors, treatment alternatives and whether another form of assessment or care should come first.
Method focus
A non-surgical CO₂ laser procedure planned for selected internal vaginal tissue, external vulval tissue or both, depending on assessment.
Clinical boundary
Nu‑V does not diagnose the cause of symptoms or replace menopause care, pelvic floor assessment, investigation or surgery where those pathways are more appropriate.
Educational only. Not a diagnosis or medical advice. Suitability is confirmed after consultation and clinical assessment. Outcomes vary. Not a cure.
Nu‑V CO₂ treatment at a glance
This is a method overview rather than an online suitability test. A symptom list alone cannot establish whether CO₂ treatment is appropriate.
Treatment category
Clinic-based, non-surgical CO₂ laser treatment.
What happens before treatment
Symptoms, medical history, likely causes, expectations, risks and alternative pathways are reviewed before any recommendation.
Treatment areas
A treatment plan may involve selected internal vaginal tissue, external vulval tissue or both where clinically appropriate.
Typical procedure time
The Nu‑V procedure itself is typically around 15 minutes. Consultation, assessment, preparation and aftercare discussion are separate.
Individual treatment planning
A single treatment, structured course or later maintenance is discussed only after individual review and is not automatically required.
Not a universal pathway
Some concerns are better addressed through medical care, menopause support, pelvic floor treatment, dermatology, investigation or surgical assessment.
Empowering Women's Intimate Health: NuV Laser Treatment & Success Stories with Dr. Farzana Khan
"I Felt Juicy Again": A Real Conversation on Menopause & Intimacy | EmpowerHer EP 01
Having a Nu-V 'Vagina Facelift' Changed My Life for the Better ITV This Morning
Sara Carson BBC Radio 2 21112017
Assessment before method selection
A treatment name cannot explain why something has changed
Searches for CO2 vaginal laser or laser vaginal rejuvenation often begin with a personal concern. That search may help you find information, but it cannot identify the cause or confirm that CO₂ treatment is appropriate.
Similar concerns may sit within very different clinical contexts, including hormonal change, pelvic floor dysfunction, childbirth-related change, vulval skin conditions, infection, prolapse, scarring, medication effects or symptoms requiring further investigation.
Nu‑V is considered only after those possibilities have been reviewed. In some cases, the most appropriate recommendation may be another form of care rather than CO₂ treatment.
How a Nu‑V treatment decision is made
The presence of a symptom does not create an automatic indication for CO₂ laser treatment. The decision follows a sequence of assessment, interpretation and informed discussion.
Stage 1
Reason for enquiry
We begin with what you have noticed, when it began, how it affects you and what you hope to understand or change.
Stage 2
Clinical context
Medical history, life stage, previous treatment, symptom pattern, screening history, possible red flags and relevant examination findings are considered.
Stage 3
Method suitability
We consider whether the clinical findings and treatment objectives reasonably align with the limited and specific role of the Nu‑V CO₂ method.
Stage 4
Informed treatment choice
The evidence, uncertainties, possible risks, expected limitations, costs and relevant alternatives are explained before you decide whether to proceed.
What assessment may establish
Whether Nu‑V belongs in the treatment discussion
The assessment may support a conversation about Nu‑V, identify a reason to delay treatment, or show that a different pathway should be considered first.
What a webpage cannot establish
Personal suitability or a predicted result
Online information can explain the procedure, but it cannot diagnose a concern, exclude other causes, confirm the correct treatment area or predict an individual response.
Suitability, treatment planning and consent must therefore be completed individually.
Nu‑V is a method decision, not a symptom label
Dryness, discomfort, a feeling of laxity, urinary symptoms or postpartum and menopause-related changes should not be treated as automatic reasons for CO₂ laser treatment. Each concern needs to be understood in its own clinical context.
What is Nu‑V CO₂ intimate rejuvenation?
Nu‑V CO₂ intimate rejuvenation is the name used by The Women’s Health Clinic for a non-surgical, clinic-based CO₂ laser procedure involving selected vaginal or vulval treatment areas after consultation and assessment.
It is one specific method within the wider vaginal rejuvenation field. It is not another name for the whole category, and it does not describe every treatment used for intimate health concerns.
What “CO₂” describes
CO₂ refers to the carbon dioxide laser technology used to deliver energy according to the treatment protocol.
The term does not mean that every CO₂ device, setting, protocol, treatment area, clinical indication or body of evidence is identical.
Internal and external planning
The vagina is the internal canal. The vulva is the external intimate area, including the labia and vaginal opening.
A Nu‑V plan may involve selected internal tissue, selected external tissue or both. The intended treatment area must be determined individually rather than assumed from a search term or symptom alone.
What the name does not establish
“CO₂ intimate rejuvenation” is not a diagnosis, clinical indication, guarantee of suitability or promise of improvement.
The name also does not establish how many sessions may be discussed, whether maintenance will be appropriate or whether another pathway would be more suitable.
Method definition
A precise way to describe Nu‑V
Nu‑V CO₂ intimate rejuvenation is an assessment-led, non-surgical laser procedure offered by The Women’s Health Clinic. Where treatment is considered appropriate, selected vaginal or vulval tissue is treated under an individual clinical plan.
Terms patients may encounter online
These phrases are often used interchangeably in online searches. On this page, they are explained in relation to the Nu‑V CO₂ method only. They should not be interpreted as interchangeable with every vaginal rejuvenation procedure or every form of intimate healthcare.
The boundary between information and recommendation
This page explains what Nu‑V is, how the pathway is organised and what questions should be considered. A recommendation can only follow an individual consultation, appropriate assessment and informed discussion of the evidence, risks, limitations and alternatives.
Who may ask about Nu‑V CO₂ treatment?
Women explore CO2 vaginal laser treatment at different life stages and for different reasons. These reasons explain why someone may seek assessment; they do not confirm that Nu‑V is suitable.
The same concern can arise from hormonal, structural, pelvic-floor, dermatological, infectious or other medical factors. The clinical context determines the next step.
After childbirth
Some women notice changes in comfort, support, sensation or how the vaginal area feels after vaginal birth, tearing, episiotomy or more than one delivery.
Assessment helps distinguish more superficial tissue concerns from pelvic-floor weakness, scar-related discomfort, muscle separation, prolapse or structural change that CO₂ treatment cannot repair.
During perimenopause or after menopause
Hormonal change can affect the vulva, vagina, bladder and urethra. Women may notice dryness, irritation, altered comfort or urinary symptoms and then encounter vaginal laser treatment while researching possible options.
Established menopause care, lubricants, moisturisers, vaginal oestrogen where suitable, and investigation of other causes should be discussed. CO₂ treatment is not automatically the next step.
When looking for a non-hormonal discussion
Some women cannot use, prefer not to use or remain uncertain about hormonal treatment. That may lead them to investigate energy-based options.
Nu‑V should not be presented as an automatic substitute for hormonal or established conservative care. The reason for avoiding a treatment and the evidence for each alternative must be considered individually.
When comparing laser with structural treatment
CO₂ laser treatment and surgery do not address the same tissue layers or clinical problems.
Nu‑V is an energy-based procedure involving selected surface and mucosal tissue. Surgery can address deeper muscle, fascia, perineal damage, prolapse or more significant structural laxity.
Important distinction
A reason for enquiring is not an indication for treatment
Search phrases such as “laser for vaginal dryness”, “laser vaginal tightening” or “CO2 laser after menopause” describe what a person is researching. They do not establish diagnosis, suitability or an expected result.
Before Nu‑V is discussed, the clinician may need to consider:
What we assess before considering Nu‑V
Women may use similar words to describe very different clinical situations. Assessment is intended to understand the concern before selecting a method.
Reasons women may seek an intimate health assessment include:
This list describes common reasons for seeking help. It is not a list of conditions that Nu‑V is proven or guaranteed to treat.
Hormonal and medical context
Dryness, irritation and tissue fragility may be associated with menopause, breastfeeding, medication, cancer treatment or other medical factors.
The relevant medical and conservative options should be considered before deciding whether an energy-based procedure has a role.
Pelvic-floor and structural context
A feeling of looseness, pressure or leakage may involve muscle function, fascial support, prolapse or childbirth-related injury.
CO₂ treatment does not perform pelvic-floor strengthening or repair significant structural separation.
Vulval, infectious and other causes
Pain, burning, irritation or tissue change can also arise from infection, inflammatory skin disease, scarring, lesions or another condition requiring diagnosis.
An energy-based treatment should not be used to bypass investigation of an unexplained symptom.
When treatment may need to be delayed, avoided or referred
Nu‑V may not be appropriate, or further review may be required first, where there is:
Possible outcome 1
Nu‑V remains an option for discussion
The findings may support an informed conversation about the procedure, its limited treatment objectives, risks and uncertainties.
Possible outcome 2
Another pathway should come first
Medical treatment, menopause care, pelvic-floor support, investigation or treatment of another condition may be the more appropriate first step.
Possible outcome 3
CO₂ treatment is not recommended
Where the method does not match the clinical concern, we explain why and discuss an alternative or onward referral where appropriate.
What CO₂ treatment is intended to do
CO₂ laser technology delivers controlled energy to selected tissue. The intended biological response is different from direct muscle strengthening, surgical tightening or structural repair.
Intended tissue response
The procedure creates a controlled thermal effect in selected mucosal or external tissue. This is intended to initiate a healing and remodelling response.
That mechanism does not prove that an individual symptom will improve, and it does not establish that the method is appropriate for every clinical indication.
Device type, settings, treatment area, protocol, patient selection and clinical indication all matter.
Controlled energy delivery
CO₂ laser energy is delivered according to the selected treatment area and clinical protocol rather than applied as a general treatment for all symptoms.
Superficial tissue focus
The procedure focuses on selected vaginal lining or external vulval tissue. It does not directly repair deeper pelvic-floor muscle or fascial support.
Defined treatment area
Internal treatment, external treatment or a combined plan should only be selected after the relevant anatomy and treatment objective have been assessed.
Short clinic procedure
The Nu‑V treatment itself is typically around 15 minutes. Clinical consultation, preparation, consent and aftercare discussion are separate.
Important limitations
What Nu‑V does not do
It does not diagnose the cause of a symptom.
It does not strengthen pelvic-floor muscles.
It does not repair significant prolapse or deep structural separation.
It does not reverse menopause or ageing.
It does not guarantee vaginal tightening, lubrication or comfort.
It does not guarantee sexual, urinary or confidence-related outcomes.
Treatment objectives that may be discussed
Depending on the clinical context, a woman may wish to discuss tissue quality, hydration, comfort, a feeling of mild laxity or another specific concern. These are discussion objectives, not promised results.
Whether CO₂ treatment has an appropriate evidence base for a specific objective must be considered separately during consent.
How Nu‑V CO₂ treatment works
The procedure is only one stage of the pathway. Assessment, informed consent and aftercare are equally important.
1. Introductory call
A free introductory call allows you to ask initial questions and understand the service. It is not the required clinical consultation and cannot confirm suitability.
2. Clinical consultation and assessment
Symptoms, medical history, screening context, likely causes, treatment objectives and relevant examination findings are reviewed.
3. Decision and informed consent
The evidence, uncertainty, possible risks, alternatives, treatment area, fees and limitations are explained before you decide whether to proceed.
4. Treatment and aftercare
Where appropriate, the selected internal or external area is treated according to the clinical plan. Written aftercare and contact guidance are provided.
During the procedure
What the Nu‑V session involves
The procedure uses a CO₂ laser system to deliver controlled energy to the treatment area identified during assessment.
Internal treatment
A clinical applicator may be used to treat selected areas of the vaginal lining according to the agreed plan.
External treatment
Selected external vulval tissue may be treated where this has been assessed and included in the consented plan.
Treatment time
The Nu‑V procedure itself is typically around 15 minutes, although the total appointment is longer.
Comfort
Individual sensation varies. The clinician explains what may be felt and any appropriate comfort measures before treatment.
Different methods, different tissue targets
CO₂ laser is not the same as pelvic-floor therapy or surgery
These pathways may all be discussed in intimate healthcare, but they work in different ways and are not interchangeable.
Nu‑V CO₂ treatment
An energy-based procedure involving selected vaginal lining or external vulval tissue.
Pelvic-floor treatment
Assessment and rehabilitation of muscle function, coordination, strength and related symptoms.
Surgical assessment
Consideration of deeper structural repair where there is significant laxity, prolapse, muscle separation or perineal change.
For a wider overview of method categories, visit our vaginal rejuvenation guide.
Recovery and temporary effects
Some women return to gentle daily activity soon after treatment. Temporary warmth, irritation, swelling, spotting or discharge may occur.
Your clinician will explain what is expected, what is not expected and when to contact the clinic.
Short-term aftercare restrictions
You may be advised temporarily to avoid intercourse, tampons, douching, swimming, hot baths, cycling, heavy lifting or strenuous exercise.
The exact advice and duration depend on the area treated and your individual clinical plan.
Response, review and maintenance
What to expect after treatment
Individual response cannot be predicted from a webpage, symptom list or treatment package.
When might change be noticed?
Any response and its timing vary. Early subjective change does not by itself establish a durable treatment effect.
How long might it last?
Duration is not guaranteed. Life stage, hormonal context, tissue characteristics, underlying cause and the treatment objective may all influence follow-up planning.
Is repeat treatment automatic?
No. A course or later maintenance should be discussed only where clinically appropriate and after reviewing response, risks and continuing goals.
Why the clinical pathway matters
An intimate CO₂ treatment should not begin with device selection alone. Safe care depends on assessment, clinician training, appropriate consent, a defined protocol and access to follow-up.
The Women’s Health Clinic approaches Nu‑V as one method within clinical decision-making rather than a universal wellness treatment.
Assessment before device treatment
The presenting concern, relevant history, possible causes, contraindications and treatment alternatives are reviewed before a recommendation is made.
Treatment by an appropriate clinician
The treatment area, device settings, procedure plan and aftercare must be selected and delivered within the clinician’s training, competence and clinical protocol.
Consent that includes uncertainty
Consent should cover not only common temporary effects, but also evidence limitations, uncommon complications, alternatives and the possibility of little or no improvement.
Another route when needed
Where Nu‑V does not match the concern, we explain the limitation and discuss medical care, pelvic-floor support, further investigation or specialist referral as appropriate.
Written aftercare and contact guidance
Patients receive guidance about expected temporary effects, restrictions, warning signs and how to contact the clinic if they are concerned.
Review rather than automatic retreatment
Further treatment should follow review of response, continuing suitability and updated goals rather than being assumed from the outset.
Nu‑V CO₂ treatment pricing
Consultation and assessment are required before treatment
The free introductory call and the required clinical consultation are different stages. Treatment is booked only after suitability has been assessed.
Nurse-led Nu‑V
One treatment where this is considered appropriate after consultation and clinical assessment.
Single treatment fee
Nurse-led Nu‑V
A three-treatment package where a structured course is recommended following assessment.
£400 × 3 treatments
A package is not automatically required.
Nurse-led annual top-up
A later top-up may be discussed after review where continuing treatment remains suitable.
Annual top-up fee
Doctor-led treatment option
Nu‑V with a doctor
Doctor-led treatment fees differ from nurse-led treatment fees.
Single treatment
£799
Doctor-led
Triple package
£1,800
Doctor-led course
Annual top-up
£600
Doctor-led maintenance
Required consultation with Dr Farzana Khan
10-minute telephone consultation
Initial clinical consultation option
£45
20-minute face-to-face consultation
In-clinic clinical consultation
£95
How the telephone consultation fee is handled
If you proceed after the £45 telephone consultation, an additional £50 is collected at booking. This brings the consultation fee to £95.
The £95 consultation fee is then deducted from the treatment fee.
Where the deduction is applied
For a single treatment, it is deducted from the treatment fee.
For a triple package, it is deducted from the third treatment.
Treatment fees apply only after clinical suitability has been confirmed.
Consultation and care
What matters during an intimate treatment journey
A responsible experience is not measured only by whether treatment is performed. Clarity, privacy, informed choice and appropriate follow-up matter throughout.
Women often value being able to describe an intimate concern without embarrassment, understand why a treatment may or may not fit, and make a decision without pressure. Individual treatment experiences and outcomes vary.
Respectful discussion
The starting point is a calm conversation about what has changed, what concerns you and what you hope to understand.
Clear clinical boundaries
You should understand what Nu‑V may reasonably be considered for, what it cannot achieve and when another route is more appropriate.
Support after the appointment
Written aftercare, warning signs and a clear route back to the clinic are important parts of the treatment process.
From research to informed choice
A typical Nu‑V enquiry pathway
Not every enquiry leads to CO₂ treatment. The pathway is designed to establish whether the method belongs in the discussion.
1. She notices a change
A concern involving comfort, dryness, support, tissue change or confidence leads her to look for information.
2. She encounters CO₂ laser online
Search results may use terms such as laser vaginal rejuvenation, CO2 vaginal laser or non-surgical vaginal tightening.
3. She asks an initial question
A free introductory call helps explain the service and the need for separate clinical assessment.
4. The concern is assessed
Medical context, possible causes, contraindications, alternatives and the limits of the method are considered.
5. She receives an appropriate plan
That plan may include Nu‑V, another form of care, further investigation or no procedure at all.
Nu‑V CO₂ Intimate Rejuvenation FAQs
Clear answers about terminology, assessment, evidence, treatment, risks, aftercare and pricing.
Nu‑V is the name used by The Women’s Health Clinic for an assessment-led, clinic-based CO₂ laser procedure involving selected vaginal or vulval treatment areas. It is one method within the wider vaginal rejuvenation field.
The phrases are often used interchangeably in online searches. On this page, they refer specifically to the Nu‑V CO₂ method. They do not describe every vaginal rejuvenation treatment or every form of intimate healthcare.
No. Vaginal rejuvenation is a broad consumer term covering different medical, conservative, energy-based, injectable and surgical pathways. Nu‑V is one particular CO₂ laser method.
CO₂ treatment does not directly tighten pelvic-floor muscle or perform structural repair. It delivers controlled energy to selected superficial tissue with the intention of initiating a tissue response. It should not be presented as a proven or guaranteed way to tighten vaginal walls.
Women may enquire because of dryness, irritation, altered comfort, a feeling of laxity, postpartum change, tissue-quality concerns or urinary symptoms. These are reasons for seeking assessment, not automatic indications for CO₂ treatment.
Menopause-related dryness and GSM should be assessed properly, and established options such as vaginal moisturisers, lubricants and vaginal oestrogen where suitable should be discussed. NICE guidance for transvaginal laser therapy specifically for urogenital atrophy remains cautious and recommends use only in the context of research because long-term safety and efficacy evidence is inadequate.
Urinary leakage can have different causes and may require pelvic-floor assessment, conservative treatment, medical review or specialist investigation. Nu‑V should not be presented as a universal or guaranteed treatment for stress urinary incontinence.
Pain during intimacy is a symptom rather than a diagnosis. It may relate to hormonal change, infection, pelvic-floor tension, vulval skin disease, scarring, endometriosis or another cause. Diagnosis and appropriate treatment should come before any energy-based procedure is considered.
The device delivers controlled CO₂ laser energy to selected tissue. The intended effect is to initiate a healing and remodelling response. This mechanism does not guarantee symptom improvement or establish suitability for a particular clinical indication.
A treatment plan may involve selected internal vaginal tissue, selected external vulval tissue or both. The area must be assessed and agreed during consent rather than assumed from a symptom or search term.
The Nu‑V procedure itself is typically around 15 minutes. The overall appointment is longer because preparation, confirmation of consent and aftercare discussion are separate.
There is no single answer for everyone. A single treatment or structured course may be discussed only after assessment. A package should not be assumed to be necessary before suitability and treatment objectives are reviewed.
Individual sensation varies, so the treatment should not be described as universally painless. The clinician will explain what may be felt, the intended treatment area and any appropriate comfort measures.
Some women return to gentle daily activity soon after treatment. Temporary warmth, irritation, swelling, spotting or discharge may occur. Written aftercare will explain what to avoid and when to contact the clinic.
Possible effects include temporary irritation, warmth, swelling, spotting, discharge or discomfort. Less common but more serious complications may include infection, thermal injury, scarring, persistent pain or altered sensation. Risks are discussed during consent.
Treatment may need to be delayed, avoided or referred where there is pregnancy, breastfeeding, active infection, unexplained bleeding, an undiagnosed lesion, abnormal screening concerns, significant prolapse, severe unexplained pain, pelvic radiation or mesh history, or another medical contraindication.
The evidence is indication-specific and varies by device, protocol, study design and follow-up period. Some studies report positive changes, while higher-quality controlled research and guideline bodies remain cautious for important indications. Nu‑V should therefore not be presented as a proven treatment for every vaginal, urinary or menopause-related concern.
No. Nu‑V is a non-surgical energy-based procedure involving selected superficial tissue. Surgery can address deeper muscle, fascia, prolapse, perineal damage or more significant structural laxity.
Nurse-led treatment is £599 for one treatment, £1,200 for a triple package and £400 for an annual top-up. Doctor-led treatment is £799 for one treatment, £1,800 for a triple package and £600 for an annual top-up. Consultation fees apply separately as explained on this page.
Yes. The free introductory call does not replace the required clinical consultation and assessment. Suitability, risks, alternatives and treatment planning must be reviewed before treatment is booked.
Your next steps
1. Book a free introductory call
2. Explain what has changed
3. Arrange the required clinical consultation
4. Understand whether Nu‑V belongs in the discussion
5. Proceed only after informed consent
What does the evidence for vaginal laser treatment mean?
Vaginal laser evidence cannot be reduced to a single statement that “laser works” or “laser does not work”. Research differs by indication, patient group, device, wavelength, settings, protocol, comparator, outcome measure and duration of follow-up.
Indication matters
Evidence concerning urogenital atrophy cannot automatically be applied to laxity, urinary symptoms, vulval treatment or another clinical objective.
Technology and protocol matter
CO₂ and other energy-based devices do not all use the same wavelength, tissue interaction, settings, treatment schedule or technique.
Study design matters
Uncontrolled improvement reports, observational studies and randomised sham-controlled trials provide different levels of certainty.
Current NICE position for urogenital atrophy
NICE HealthTech guidance 582 addresses transvaginal laser therapy specifically for urogenital atrophy. It states that evidence on long-term safety and efficacy is inadequate in quality and quantity and recommends that the procedure should only be used in the context of research for that indication.
The same guidance notes that the available evidence did not show short-term safety concerns, while still identifying inadequate long-term evidence.
Read NICE HTG582What this means for responsible treatment choice
CO₂ treatment should not be marketed as routine treatment for every vaginal, urinary, postpartum or menopause-related concern. Where it is discussed, consent should identify the precise treatment objective, the relevant evidence, uncertainty, possible risks, established alternatives and the possibility of little or no improvement.
Wording we avoid
Claims that overstate the method
Wording we use
Language that reflects informed choice
Method-specific page boundary
This page explains CO₂ treatment only
It does not duplicate the full menu of vaginal rejuvenation options. Different methods have different mechanisms, evidence, indications, risks and regulatory considerations.
Use the main vaginal rejuvenation guide when you need to compare wider medical, conservative, non-surgical and surgical pathways rather than research the Nu‑V CO₂ method specifically.
Visit the vaginal rejuvenation overviewRelated Intimate Health Guides
Read expert women’s health articles
Explore our expert medical articles covering women’s health, menopause, intimate health and preventative care.
Dr. Hany Mostafa
Specialist in obstetrics & gynaecology Dr. Hany Mostafa is a Consultant Obstetrician and Gynaecologist specializing in reproductive medicine…
Read MoreStill not sure where to start?
Browse the wider treatment pages or book a free consultation.
Browse our women’s health FAQs
Find clear answers to common questions about consultations, treatments, symptoms, preparation, aftercare and pricing.
